Live Breaking News & Updates on Prescription drug markets part
Stay updated with breaking news from Prescription drug markets part. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At the second General Session of the 2023 NCPA Annual Convention at the Orange County Convention Center, NCPA President Hugh Chancy took the stage to the chorus of Survivor's 1982 song "Eye of the Tiger" to welcome a packed hall. Chancy introduced Rep. James Comer (R-Ky.), who received a standing ovation and an enthusiastic round of applause.
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and...
This Week in Washington: House stalls on defense spending bill, but begins negotiations among Republicans on appropriations; Senate was expected to move forward on three appropriations...
Today, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) will be a holding hearing titled, “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part II: Not What the Doctor Ordered.” At the hearing, members will be looking at pricing tactics deployed by PBMs to enrich themselves at the expense of patients across the country. The hearing will take place at 10 a.m. ET and feature testimony by NCPA President Hugh Chancy.
PBMs are driving up drug prices through fees, PhRMA report claims healthcarefinancenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcarefinancenews.com Daily Mail and Mail on Sunday newspapers.
House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) will lead tomorrow's hearing titled, “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part II: Not What the Doctor Ordered,” which will feature testimony by NCPA President Hugh Chancy. At the hearing, members will examine pricing tactics deployed by PBMs to enrich themselves at the expense of patients across the country.